New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 6, 2013
07:39 EDTHZNPHorizon Pharma announces Notice of Allowance from USPTO covering Rayos
Horizon Pharma announced that Skyepharma has received a Notice of Allowance from the United States Patent and Trademark Office, or USPTO, for U.S. Patent Application 13/428,548 entitled "Delayed Release Tablet with Defined Core Geometry" that covers the company's U.S. approved product Rayos. This Notice of Allowance concludes the substantive examination of the patent application and will result in the issuance of a U.S. patent after administrative processes are completed. The U.S. patent scheduled to issue from this application will expire in 2024. After issuance, Horizon plans to list the U.S. patent in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book. This will be the third U.S. patent to be listed in the Orange Book for Rayos.
News For HZNP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
07:22 EDTHZNPHorizon Pharma granted Notice of Allowance for Pennsaid by USPTO
Subscribe for More Information
August 21, 2015
13:04 EDTHZNPDepomed to file revocation statement with SEC
Subscribe for More Information
August 20, 2015
07:03 EDTHZNPHorizon Pharma issued Notice of Allowance by USPTO covering Vimovo
Subscribe for More Information
August 19, 2015
17:40 EDTHZNPDepomed sends letter to Horizon Pharma CEO
Subscribe for More Information
17:36 EDTHZNPDepomed board unanimously rejects revised proposal from Horizon Pharma
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use